| PERIOD ENDING | 2-Jan-09 | 28-Dec-07 | 29-Dec-06 | | Total Revenue | 74,894 | 59,363 | 56,282 | | Cost of Revenue | 34,787 | 30,097 | 29,849 | | | Gross Profit | 40,107 | 29,266 | 26,433 | | | Operating Expenses | | Research Development | 7,938 | 6,711 | 7,080 | | Selling General and Administrative | 52,556 | 36,674 | 33,286 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
| (331) | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (20,387) | (14,119) | (13,602) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (384) | (271) | 242 | | Earnings Before Interest And Taxes | (20,771) | (14,670) | (13,246) | | Interest Expense | 901 | 486 | 261 | | Income Before Tax | (21,672) | (15,156) | (13,507) | | Income Tax Expense | 1,523 | 843 | 1,537 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,195) | (15,999) | (15,044) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (23,195) | (15,999) | (15,044) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,195) | ($15,999) | ($15,044) |
|
1.52% Nasdaq 0.00%
Income Statement
